New drug hope for child asthma

June 2006
Pulse;6/8/2006, Vol. 66 Issue 23, p2
The article talks about leukotriene receptor antagonist as a means of controlling symptoms in children with mild asthma. According to a study of general practice in Great Britain, it is substantially better to use a leukotriene receptor antagonist than inhaled steroids in controlling the symptoms of mild asthma in children.


Related Articles

  • Zafirlukast: A Review of its Pharmacology and Therapeutic Potential in the Management of Asthma. Adkins, J.C.; Brogden, R.N. // Drugs;Jan1998, Vol. 55 Issue 1, p121 

    Zafirlukast is a competitive and selective leukotriene receptor antagonist indicated for the prophylaxis and treatment of chronic asthma. The rationale for the development of leukotriene antagonists was based on in vitro and in vivo data demonstrating the extensive role of the cysteinyl...

  • Insufficient evidence that addition of montelukast to inhaled corticosteroids improves treatment of asthma.  // Australian Journal of Pharmacy;Jun2011, Vol. 92 Issue 1093, p82 

    The article discusses a meta-analysis of the efficiency of inhaled corticosteroids (ICS) combined with montelukast (MONT) which may improve treatment of asthma in children.

  • ASTHMA FIRST AID CHARTS LAUNCHED.  // Air Quality & Climate Change;May2012, Vol. 46 Issue 2, pEI-6 

    The article announces that updates were made to the popular "First Aid for Asthma" chart from the National Asthma Council Australia which include a new paediatric "Kids' First Aid for Asthma" chart that contains new evidence and medications.

  • Prevention Puzzle. Langreth, Robert // Forbes Global;2/9/2004, Vol. 7 Issue 2, p60 

    Presents information on a study conducted on asthma drugs called leukotriene inhibitors. Use of the drug in preventing heart attacks; Potentials of the drug; Competition among drug companies in discovering the effect of leukotriene inhibitors on heart diseases.

  • montelukast. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p513 

    An encyclopedia entry for "montelukast" is presented. It is a specific leukotriene receptor antagonist drug used in the management of asthma. It is not used to treat acute asthma attacks.

  • LABAs alone too risky to treat asthma in children.  // Contemporary Pediatrics;Jan2009, Vol. 26 Issue 1, p22 

    The article reports that the adviser of the U.S. Food and Drug Administration have warned that two single-agent long-acting beta2 agonist (LABA) inhalers should have their pediatric asthma indications discontinued. They added that the two drugs, salmeterol and formoterol, carry high risks for...

  • Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new users.  // BMC Pulmonary Medicine;2011, Vol. 11 Issue 1, p48 

    The article presents a study focusing on prescribing anti-asthma medication to children in the Lombardy Region of Italy. This study allowed a proxy of asthma incidence, prevalence, and severity. The analyses done during the study shows a low compliance with the guidelines, indicating that...

  • ... And for 6- to 14-year-old Children with Asthma.  // Modern Medicine;Oct98, Vol. 66 Issue 10, p50 

    Discusses the abstract of the study `Montelukast for chronic asthma in 6-to 14-year-old children: A randomized, double-blind trial,' published in the April 15, 1998 issue of the `Journal of the American Medical Association' periodical.

  • Parent-initiated steroids can improve asthma in children.  // Pulse;3/10/2010, Vol. 70 Issue 8, p9 

    The article presents a study conducted by Australian researchers which found out that short course use of oral prednisolone initiated by parents when their child experiences acute asthma attack reduces asthma symptoms.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics